Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
harvard pilgrim health care
3
×
life sciences
national blog main
national top stories
new york blog main
alnylam pharmaceuticals
boston
fda
gene therapy
institute for clinical and economic review
luxturna
new york top stories
spark therapeutics
achromatopsia
akcea therapeutics
amy schulman
andreas klein
anna greka
barry greene
beta-thalassemia
bill cassidy
bluebird bio
car-t
caron jacobson
cigall kadoch
clinical trials
craig mello
dan ollendorf
deals
dna
drugs
european medicines agency
events
foghorn therapeutics
goldfinch biopharma
hemophilia
hereditary transthyretin amyloidosis
inotersen
What
gene
3
×
interference
rna
therapy
age
alnylam
approves
aren’t
bigger
biggest
car
cells
come
cutting
deal
drug
edge
ema
emerging
employ
europe
experiments
fda
follows
gave
harmful
hits
hot
j
johnson
launch
make
market
medicine
medicines
meiragtx
method
morning
mute
past
Language
Current search:
gene
×
" harvard pilgrim health care "
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
6 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”